PDS Biotechnology Corporation (NASDAQ: PDSB) established initial surge of 5.00% at $0.95, as the Stock market unbolted on Wednesday, before settling in for the price of $0.91 at the close. Taking a more long-term approach, PDSB posted a 52-week range of $0.70-$2.20.
The Healthcare sector firm’s twelve-monthly sales growth has been 6.42% for the last half of the decade. Meanwhile, its Annual Earning per share during the time was 6.42%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 22.33%. This publicly-traded company’s shares outstanding now amounts to $54.72 million, simultaneously with a float of $53.31 million. The organization now has a market capitalization sitting at $52.15 million. At the time of writing, stock’s 50-day Moving Average stood at $0.8780, while the 200-day Moving Average is $1.1415.
PDS Biotechnology Corporation (PDSB) Ownership Facts and Figures
Sometimes it is also beneficial to study the sentiment of large-scale investors towards the stock of the PDS Biotechnology Corporation industry. PDS Biotechnology Corporation’s current insider ownership accounts for 2.58%, in contrast to 10.30% institutional ownership. According to the most recent insider trade that took place on Feb 28 ’25, this organization’s Director bought 15,060 shares at the rate of 1.66, making the entire transaction reach 25,000 in total value, affecting insider ownership by 61,213. Preceding that transaction, on Feb 28 ’25, Company’s Director bought 15,061 for 1.66, making the whole transaction’s value amount to 25,001. This particular insider is now the holder of 78,851 in total.
PDS Biotechnology Corporation (PDSB) Earnings and Revenue Records
PDS Biotechnology Corporation’s EPS increase for this current 12-month fiscal period is 22.33% and is forecasted to reach -0.67 in the upcoming year. Considering the longer run, market analysts have predicted that Company’s EPS will increase by 12.71% through the next 5 years, which can be compared against the 6.42% growth it accomplished over the previous five years trading on the market.
PDS Biotechnology Corporation (NASDAQ: PDSB) Trading Performance Indicators
Let’s observe the current performance indicators for PDS Biotechnology Corporation (PDSB). It’s Quick Ratio in the last reported quarter now stands at 2.09.
In the same vein, PDSB’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -0.82, a figure that is expected to reach -0.20 in the next quarter, and analysts are predicting that it will be -0.67 at the market close of one year from today.
Technical Analysis of PDS Biotechnology Corporation (PDSB)
Now, what If we examine the latest scores posted by [PDS Biotechnology Corporation, PDSB]. During the last 5-days, its volume was better the volume of 0.39 million it reported in year-ago period. During the previous 9 days, stock’s Stochastic %D was recorded 74.95% While, its Average True Range was 62.84.
Raw Stochastic average of PDS Biotechnology Corporation (PDSB) in the period of the previous 100 days is set at 32.59%, which indicates a major fall in contrast to 83.85% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 0.0632 that was lower than 0.0748 volatility it exhibited in the past 100-days period.
